SciSparc: Subsidiary NeuroThera Labs Reports Positive Progress in FDA-Approved Phase IIb Clinical Trial for Tourette Syndrome

Stock Information for SciSparc Ltd.

Loading

Please wait while we load your information from QuoteMedia.